Anti-DCBLD2 Antilichaam

DCBLD2, also known as ESDN or CLCP1, was first identified from human coronary arterial cells by a signal sequence trap method. DCBLD2 regulates proliferation, migration, and invasion in various tumors, including glioma, hypopharyngeal squamous cell carcinoma, and myxofibrosarcoma. The human DCBLD2 protein has a predicted molecular mass of ∼80 kDa based on its amino acid sequence, although it regularly displays an effective molecular mass of ∼130 kDa via SDS-PAGE (PMID: 30902898) .

Boster Bio Anti-DCBLD2 Antibody catalog # A09768. Tested in WB, IHC, IP, ELISA applications. This antibody reacts with Human.

ESDN; Endothelial and smooth muscle cell-derived neuropilin-like protein; Discoidin; CUB and LCCL domain-containing protein 2; CUB; LCCL and coagulation factor V/VIII-homology domains protein 1; CLCP1

DCBLD2

Q96PD2

Human

E.coli-derived human DCBLD2 recombinant protein (Position: L521-E741) .

WB, IHC, IP, ELISA

Immunogen affinity purified.

500 μg/mL

Liquid

12 months from date of receipt, -20°C as supplied. 6 months 2 to 8°C after reconstitution. Avoid repeated freezing and thawing.

https://www.bosterbio.com/msds?sku=A09768

Discoidin, CUB and LCCL domain containing 2

Discoidin, CUB and LCCL domain-containing protein 2

500 μg/mL antibody with PBS,0.02% NaN3, 1 mg BSA and 50% glycerol.